AMANDA SANDERS: Open Payments
NPI 1417292004 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,378 in 111 payments from 21 companies in 2025. Trend: 2023 $2,638 · 2024 $3,100 · 2025 $2,378
Food & beverage: $2,370Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $393 |
| Galderma Laboratories, L.P. | 9 | $266 |
| Regeneron Healthcare Solutions, Inc. | 10 | $264 |
| GENZYME CORPORATION | 9 | $249 |
| LEO Pharma Inc. | 5 | $135 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $123 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Organon LLC | 5 | $111 |
| Lilly USA, LLC | 5 | $108 |
| Incyte Corporation | 5 | $107 |
Products named: DUPIXENT, NEMLUVIO, RINVOQ, SKYRIZI, OPZELURA, ADBRY, Otezla, Zoryve.
Industry payments across GA — which companies pay providers there.
